Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Nerac IPDex™
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Nerac Insights / Articles / Stephen Buxser, Ph.D. / New Diagnostics in Medicine – Cheap, Fast, and Accurate

New Diagnostics in Medicine – Cheap, Fast, and Accurate

Facebook0
Google+0
LinkedIn2
Twitter0

By Stephen Buxser, Ph.D. 

Originally Published: July 15, 2014

Introduction

A major, if not the major, driver of advances in medicine is the development of better diagnostics. The ability to diagnose disease is required before new therapies can be developed or, in many cases, even conceived. Of course the foundation for diagnostics is solid basic science, which provides the insight needed to understand what can and should be diagnosed. The application of the basic science to a well-defined problem requires engineering. Good engineering is needed to manufacture appropriate diagnostics, including both the introduction of new materials and manufacturing practices but also to ensure ease of use and cost effectiveness. For diagnostics the holy grail is cheap, fast and accurate but all three are rarely achieved. However, combining new technologies and better understanding of biological processes is driving advances to achieve the three goals.

Want to read the rest of the article? Fill out the form to download: New Diagnostics in Medicine – Cheap, Fast, and Accurate
Get Download Link

 

 

 

 

<

Related Posts

  • The Revolution in Next Generation Nucleic Acid Sequencing: How is it profoundly changing biology and medicine?
    77
    By Stephen Buxser, Ph.D. Nerac Analyst Originally Published: July 21, 2014 A revolution is well underway in the development and application of new nucleic acid sequencing technologies. New techniques have been developed that have profoundly increased the rate at which whole genomes and nearly any other form of DNA or RNA can be rapidly and accurately…
    Tags: sequencing, well, techniques, technologies, medicine, biology, acid, nucleic, read, outline
  • Modest Impact on Personalized Medicine Expected from Recent SCOTUS Rulings
    32
    By Roz Sweeney, Ph.D. Nerac Analyst, The recent Supreme Court decision on the Association for Molecular Pathology v. Myriad Genetics case was the culmination of much litigation on the validity of patent protection for the genomic sequences of BRCA1 and BRCA2. Myriad Genetics’ patents on these two genes gave it the exclusive right to offer genetic…
    Tags: read, dna, ph.d, personalized, medicine
  • A Glimpse into the Vital Core of Tumor Cell Development
    30
    By John Leavitt, Ph.D. Nerac Analyst Originally Published: August 12, 2014 In 1987, my colleagues at Stanford and I published a paper that clearly demonstrated that expression of a charge-altered mutant human beta-actin (glycine to aspartic acid substitution at amino acid 245; G245D) caused non-tumorigenic, immortalized human fibroblasts to form aggressive tumors in nude mice (Leavitt…
    Tags: acid, published, read, ph.d, originally, three, development, biotech
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence conflict minerals Disruptive Technologies energy EU MDR FDA food helga weires Industry 4.0 innovation Inspiring Next intellectual property IP market analysis market research medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation patenting patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance Robert Beinstein Rosemarie Szostak specialty chemicals Sustainable Development Goals technology scouting Tech Scouting XcellR8
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities
  • Privacy Policy

Copyright © 2023 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!

  • This field is for validation purposes and should be left unchanged.